Clinical-stage company ImmunoCellular Therapeutics has named Andrew Gengos as the company's president, chief executive officer and board member. Gengos has served several companies and gained experience in areas such as corporate ...
Tags: ImmunoCellular, clinical, named, company's president
US based pharmaceutical company, Amgen has acquired KAI Pharmaceuticals. The acquisition, which was initially announced on 10 April 2012, includes KAI's main product KAI-4169, an agent being studied to treat secondary hyperparathyroidism ...
Clinical stage drug development company Telik has reported a net loss of $1.88m, or $0.78 per share, for the third quarter ended 30 September 2012 compared to a net loss of $2.85m, or $1.58 per share, for the third quarter ended 30 ...
Tags: Clinical stage drug development, net loss, loss from operations
Clinical-stage biopharmaceutical company Omeros Corporation said that it has discovered the proteins that activate the alternative pathway of the complement system as part of the company's mannan-binding lectin associated serine protease-2 ...
Tags: complement system, protease-2(MASP-2)program, pro-inflammatory protein
Clinical stage biopharmaceutical company, Tocagen, has entered into a partnership agreement with MRI Interventions and Brainlab. Under the collaboration, Tocagen will use MRI Interventions' ClearPoint neuro intervention system at selected ...
Clinical-stage biopharmaceutical company OXiGENE's acute myelogenous leukemia (AML) drug candidate, OXi4503, has received FDA orphan drug status. The second-generation anticancer agent with a dual-mechanism vascular disrupting feature ...
Cytochroma, a clinical stage specialty pharmaceutical company, has selected OmniComm Systems' eClinical Suite of applications for its two Phase III studies. OmniComm's eClinical Suite, including the EDC, CTMS, Safety, and Coding ...
Tags: Cytochroma, clinical stage, eClinical Suite, patient data, adverse events